Skip to content

CBD, Nutrient Metabolism and Energy Intake

Effects of Acute Cannabidiol (CBD) Supplementation on Nutrient Metabolism and Energy Intake in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05618756
Enrollment
15
Registered
2022-11-16
Start date
2021-09-30
Completion date
2022-04-30
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetitive Behavior, Glucose Metabolism Disorders (Including Diabetes Mellitus), Lipid Metabolism Disorders

Brief summary

CBD may affect metabolic control and energy intake. However, there is currently little data regarding these specific outcomes in humans. Therefore, this study will investigate whether a single 300 mg dose of CBD can improve metabolic control following a meal and/or reduce energy intake at a subsequent meal. Healthy, adult volunteers will complete two conditions in a crossover design, comparing outcomes following both CBD and placebo supplementation.

Interventions

DIETARY_SUPPLEMENTAcute oral CBD supplementation

1 ml hemp oil containing 300 mg CBD, within gelatin capsules, ingested orally.

DIETARY_SUPPLEMENTAcute oral placebo supplementation

1 ml hemp oil containing no CBD, within gelatin capsules, ingested orally.

Sponsors

Loughborough University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

• Self-report as healthy, male or female, aged 18-50, body mass index ≥18.5 and \<30.0

Exclusion criteria

* Currently engage in \>10 hours moderate or vigorous intensity physical activity per week * Have consumed CBD or cannabis at all within the past two months * Have used CBD or cannabis regularly (\>2x in a week) within the past four months * Are suffering from any clinically significant illness * Have regularly used tobacco within the previous 6 months (\> 2/week) * Currently use any prescription or over-the-counter medications (except for hormonal contraception and simple painkillers) * Have given a standard blood donation within 30 days of screening * Are currently pregnant or lactating * Are allergic/intolerant to any ingredients in food items provided during the study

Design outcomes

Primary

MeasureTime frameDescription
Energy intake~5-30 minutes (time taken to eat a single meal)Self-selected energy intake at an ad libitum mixed meal
Postprandial Glycaemia3 hoursPlasma glucose response to a mixed meal (plasma glucose concentrations and area under curve)
Postprandial Triglyceridaemia3 hoursPlasma triglyceride response to a mixed meal (plasma triglyceride concentrations and area under curve)

Secondary

MeasureTime frameDescription
Postprandial Insulinaemia3 hoursPlasma Insulin response to a mixed meal (plasma insulin concentrations and area under curve)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026